Biotechnology - Vaccines

Filter

Current filters:

Vaccines

Popular Filters

1 to 25 of 68 results

Affinivax launches, aiming to develop novel conjugate vaccine

30-10-2014

Affinivax, a US biotechnology company dedicated to developing novel vaccines, today announced its launch…

AffinivaxBiotechnologyFinancialResearchVaccines

Fujifilm to expand biopharma CMO business with acquisition of Kalon

29-10-2014

Fujifilm Diosynth Biotechnologies USA, a subsidiary of Japanese digital camera and medical equipment…

BiotechnologyFujifilmFujifilm Diosynth BiotechnologiesKalon BiotherapeuticsMergers & AcquisitionsVaccines

UK cancer charity partners with Asterias Biotherapies on lung cancer vaccine

UK cancer charity partners with Asterias Biotherapies on lung cancer vaccine

15-09-2014

The charity Cancer Research UK and its commercialization arm Cancer Research Technology (CRT), have reached…

Asterias BiotherapeuticsBiotechnologyBioTimeCancer Research TechnologyLicensingOncologyResearchUKVaccines

iBio collaborates with Kanematsu Chemicals to target Japanese market

iBio collaborates with Kanematsu Chemicals to target Japanese market

14-08-2014

USA-based iBio Inc and Japan’s Kanematsu Chemicals, part of Kanematsu Corp have entered into a collaboration…

BiotechnologyBusiness FinanceiBio IncJapanKanematsuLicensingPharmacologyVaccines

Hemispherx links with SA biotech Bioclones on cancer vaccine

Hemispherx links with SA biotech Bioclones on cancer vaccine

14-07-2014

USA-based Hemispherx Biopharma has entered a strategic alliance to develop multiple projects with Bioclones,…

AlferonAmpligenBioclonesBiotechnologyHemispherx BioPharmaOncologyResearchSouth AfricaVaccines

FDA approval for Protein Sciences’ 2014/15 formulation of Flublok

FDA approval for Protein Sciences’ 2014/15 formulation of Flublok

09-07-2014

The US Food and Drug Administration has approved privately-held US biotech firm Protein Sciences’ strain…

BiotechnologyFlublokInfluenzaProtein Sciences CorpRegulationUSAVaccines

Novartis files for US approval of meningitis B vaccine Bexsero

Novartis files for US approval of meningitis B vaccine Bexsero

17-06-2014

Swiss pharma major Novartis has submitted a Biologic License Application to the US Food and Drug Administration…

BexseroBiotechnologyNovartisRegulationUSAVaccines

Novartis Vaccines appoints new Medical Affairs Director for North Europe

Novartis Vaccines appoints new Medical Affairs Director for North Europe

25-04-2014

Novartis Vaccines, the vaccination branch of Swiss drug major Novartis (NOVN: VX), has announced the…

BiotechnologyBoardroomNovartisPharmaceuticalUKVaccines

Dutch biotech Mucosis partners with Chinese firm

Dutch biotech Mucosis partners with Chinese firm

15-04-2014

Dutch biotech company Mucosis has entered into a long-term collaboration and license agreement with China-based…

BiotechnologyChangchunChief executiveChinaDiseaseHuman respiratory syncytial virusLicensingMimopath technologyNetherlandsVaccines

Valneva deal with Emergent BioSolutions for development of vaccines in the EB66 cell line

11-03-2014

European biotechnology company Valneva has signed a new research license agreement and transferred an…

BiotechnologyEB66 cell lineEmergent BioSolutionsLicensingVaccinesValneva

“Overwhelming approval” in store for Heplisav if Dynavax delivers sufficient safety data, says analyst

“Overwhelming approval” in store for Heplisav if Dynavax delivers sufficient safety data, says analyst

27-02-2014

Despite citing the need for further safety studies, both US and EU regulators have lauded the immunogenicity…

Anti-viralsBiotechnologyDynavax TechnologiesHeplisavRegulationResearchVaccines

Valneva initiates fourth antibody discovery program for Sanofi Pasteur

25-02-2014

European biotechnology company Valneva has initiated a fourth monoclonal antibody discovery program for…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSanofiSanofi PasteurVaccinesValneva

Dynavax withdraws European MAA for Heplisav

18-02-2014

US biotech firm Dynavax Technologies says it has withdrawn the European Marketing Authorization Application…

Anti-viralsBiotechnologyDynavax TechnologiesEuropeHeplisavRegulationVaccines

Creation of ABIVAX - a leader in therapeutic vaccines - in a Cuban collaboration

12-02-2014

French venture capital firm Truffle Capital has announced the creation of Paris-based ABIVAX in collaboration…

ABIVAXAnti-viralsBiotechnologyResearchVaccines

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit

07-12-2013

The Brazilian Development Bank will finance 804 million real ($342 million) for the construction of a…

BexseroBiotechnologyBrazilFinancialNovartisProductionSouth AmericaVaccines

Roche and immatics ink mega-million cancer vaccine and immunotherapy deal

Roche and immatics ink mega-million cancer vaccine and immunotherapy deal

13-11-2013

Germany’s privately-held immatics biotechnologies GmbH and Swiss drug major Roche have entered into…

BiotechnologyIMA942immatics biotechnologiesImmunologicalsOncologyRocheVaccines

H1N1 virus market to be worth $273 million by 2018

22-10-2013

The H1N1 vaccines market has been forecast to decline in value over the next five years, reaching a value…

BiotechnologyFinancialGlobalHealthcareVaccines

Theravectys raises 14.7 million euros to help pursue vaccines development

16-10-2013

French biotechnology company Theravectys has finalized a 14.7 million-euro ($19.9 million) financing…

BiotechnologyFinancialResearchTheravectysVaccines

BIA UK BioScience Forum: Accelerating vaccine development

BIA UK BioScience Forum: Accelerating vaccine development

15-10-2013

Recent advances in vaccine development in the UK were heard by interested delegates at the UK BioScience…

BiotechnologyEuropeInterviewsResearchVaccines

Vivaldi Biosciences acquires clinical stage influenza vaccine assets

13-10-2013

Privately-held US biotech firm Vivaldi Biosciences has acquired from Baxter Healthcare R&D assets, including…

Anti-viralsBaxter HealthcareBaxter InternationalBiotechnologyMergers & AcquisitionsVaccinesVivaldi Biosciences

Valneva licenses EB66 to IAVI for preventive HIV vaccine

02-10-2013

Biotech firm Valneva says that it has licensed the use of its EB66 cell line to the International AIDS…

Anti-viralsBiotechnologyLicensingVaccinesValneva

Agenus and VaxLogic licensing accord on QS-21 Stimulon adjuvant

Agenus and VaxLogic licensing accord on QS-21 Stimulon adjuvant

27-09-2013

US biotech firm Agenus has entered into a non-exclusive license agreement with VaxLogic, a subsidiary…

AgenusBiotechnologyLicensingNorth AmericaPharmLogicVaccinesVaxLogic

GlaxoSmithKline's cancer drug candidate fails endpoint in melanoma

05-09-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and partner US biotech firm Agenus (Nasdaq: AGEN) this morning…

AgenusBiotechnologyGlaxoSmithKlineMAGE-A3OncologyPharmaceuticalResearchVaccines

1 to 25 of 68 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top